-
Yao, E.; Gunder, L.; Moyer, T.; Matkowskyj, K.A.; Fox, K.; Zhou, Y.; Haggerty, S.; Johnson, H.; Sherer, N.; Carchman, E. Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer. Viruses 2024, 16, 1421. https://doi.org/10.3390/v16091421
-
Gunder, L.C.; Johnson, H.R.; Yao, E.; Moyer, T.H.; Green, H.A.; Sherer, N.; Zhang, W.; Carchman, E.H. Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease. Viruses 2023, 15, 1013. https://doi.org/10.3390/v15041013
-
-
Gunder, L.C.; Johnson H.R.; Green, H.A.; Bilger, A.; Moyer, T.H.; Zhang, W.; Ziolkowski, M.R.; Bertrang, P.A.; & Carchman, E.H. The use of a topical protease inhibitor, Saquinavir, to alleviate mouse papillomavirus-mediated anal disease. Virology 2022, 576, 96-104. https://doi.org/10.1016/j.virol.2022.09.012
-
Gunder, L.C., Moyer, T.H., Johnson, H.R., Auyeung, A.S., Leverson, G.E., Zhang, W., Matkowskyj, K.A., and Carchman, E.H., “Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors,” Journal of Surgical Research 2022; 282:137-146.
-
Gunder, L.C.; Blaine-Sauer, S.; Johnson, H.R.; Shin, M.-K.; Auyeung, A.S.; Zhang, W.; Leverson, G.E.; Ward-Shaw, E.T.; King, R.E.; McGregor, S.M.; Matkowskyj, K.A.; Lambert, P.F.; Carchman, E.H. Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models. Viruses 2022, 14, 1632. https://doi.org/10.3390/v14081632
-
-
-
